Figure 9

ROC curves illustrated the effectiveness of the methylation-related nomogram and a few known biomarkers in predicting the prognosis of stage I–II LUAD patients. The AUC in Rotunno et al. is 0.810, in Chen et al. (0.656), in Kuo et al. (0.802), in Wu et al. (0.940), in Sun et al. (0.765), in Zhao et al. (0.760), in Sun et al. (0.786).